Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Magalhaes, Isabelle ^a,b   Eriksson, Mikael ^b   Linde, Charlotte ^b   Muhammad, Rashid ^b   Rane, Lalit ^b   Ambati, Aditya ^a,b   Axelsson Robertson, Rebecca ^a,b   Khalaj, Bahareh ^b   Alvarez Corrales, Nancy ^b   Lapini, Giulia ^c   Montomoli, Emanuele ^c   Linde, Annika ^d   Pedersen, Nancy L ^b   Maeurer, Markus ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF SIENA   (Italy)

^d Swedish Institute for Communicable Disease Control   (Sweden)

Author keywords

Epidemiology; Flu antigens; H1N1; Immune protection; Influenza; Pandemic; T cells; Vaccine take

Indexed keywords

CROSS REACTING ANTIBODY; GAMMA INTERFERON; INFLUENZA VACCINE; VIRUS ANTIGEN; VIRUS RNA; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CHILD; COMPLEMENT HEMOLYSIS TEST; CONTROLLED STUDY; CORONAVIRUS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EXPOSURE; FEMALE; FLU LIKE SYNDROME; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOASSAY; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; LONGITUDINAL STUDY; MALE; SWEDEN; SYMPTOMATOLOGY; T LYMPHOCYTE; VIRUS EXAMINATION; ADOLESCENT; BLOOD; IMMUNOLOGY; INFLUENZA VIRUS A H1N1; INFLUENZA, HUMAN; METABOLISM; MIDDLE AGED; PATHOGENICITY; PROSPECTIVE STUDY; VACCINATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERFERON-GAMMA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SWEDEN; T-LYMPHOCYTES; VACCINATION; YOUNG ADULT;

EID: 84904762027     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-319     Document Type: Article

References (30)

1. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009, 360(25):2605-2615.
2. Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med 2009, 361(26):2507-2517. 10.1056/NEJMoa0906612, 20007555.
3. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, Higuera A, Mondragon E, Cordova-Villalobos JA. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361(7):680-689. 10.1056/NEJMoa0904252, 19564631.
4. Yu F, Li CW, Wei H, Liu XP, Lin D, Gong JY, Qin S, Xu FY, Mi YC, Wang JX. Identification of complex chromosomal aberrations in acute leukemia by using conventional cytogenetics combined with multiplex fluorescence in situ hybridization. Zhonghua Xue Ye Xue Za Zhi 2010, 31(5):289-293.
5. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, Liu F, Dong L, DeVos JR, Gargiullo PM, Brammer TL, Cox NJ, Tumpey TM, Katz JM. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009, 361(20):1945-1952. 10.1056/NEJMoa0906453, 19745214.
6. Qin M, Wang DY, Huang F, Nie K, Qu M, Wang M, Han F, Zhao X, Cheng YH, Shu YL, Ma XJ. [Development of single-tube multiplex real-time PCR for simultaneous detection of novel influenza A H1N1 and human seasonal influenza A H1N1 and H3N2 virus]. Bing Du Xue Bao 2010, 26(2):97-102.
7. Jamieson AM, Yu S, Annicelli CH, Medzhitov R. Influenza virus-induced glucocorticoids compromise innate host defense against a secondary bacterial infection. Cell Host Microbe 2010, 7(2):103-114. 10.1016/j.chom.2010.01.010, 2836270, 20159617.
8. Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139(7):1255-1267. 10.1016/j.cell.2009.12.018, 2892837, 20064372.
9. Centers for Disease Control and Prevention (CDC): Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009, 58(19):521-524. Centers for Disease Control and Prevention (CDC):.
10. Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, Zambon M, Miller E. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess 2010, 14(55):115-192.
11. McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983, 309(1):13-17. 10.1056/NEJM198307073090103, 6602294.
12. Topham DJ, Tripp RA, Doherty PC. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 1997, 159(11):5197-5200.
13. Almqvist C, Adami HO, Franks PW, Groop L, Ingelsson E, Kere J, Lissner L, Litton JE, Maeurer M, Michaelsson K, Palmgren J, Pershagen G, Ploner A, Sullivan PF, Tybring G, Pedersen NL. LifeGene-a large prospective population-based study of global relevance. Eur J Epidemiol 2011, 26(1):67-77. 10.1007/s10654-010-9521-x, 21104112.
14. Qin M, Wang DY, Huang F, Nie K, Qu M, Wang M, Shu YL, Ma XJ. Detection of pandemic influenza A H1N1 virus by multiplex reverse transcription-PCR with a GeXP analyzer. J Virol Methods 2010, 168(1-2):255-258.
15. Rizzo C, Rota MC, Bella A, Alfonsi V, Declich S, Caporali MG, Ranghiasci A, Lapini G, Piccirella S, Salmaso S, Montomoli E. Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine 2010, 28(20):3558-3562. 10.1016/j.vaccine.2010.03.006, 20307592.
16. Garcia-Canas V, Lorbetskie B, Cyr TD, Hefford MA, Smith S, Girard M. Approach to the profiling and characterization of influenza vaccine constituents by the combined use of size-exclusion chromatography, gel electrophoresis and mass spectrometry. Biologicals 2010, 38(2):294-302. 10.1016/j.biologicals.2009.12.005, 20074977.
17. Sakaguchi T, Leser GP, Lamb RA. The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol 1996, 133(4):733-747. 10.1083/jcb.133.4.733, 2120830, 8666660.
18. Heiny AT, Miotto O, Srinivasan KN, Khan AM, Zhang GL, Brusic V, Tan TW, August JT. Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS One 2007, 2(11):e1190. 10.1371/journal.pone.0001190, 2065905, 18030326.
19. Lee LY, Ha do LA, Simmons C, de Jong MD, Chau NV, Schumacher R, Peng YC, McMichael AJ, Farrar JJ, Smith GL, Townsend AR, Askonas BA, Rowland-Jones S, Dong T. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008, 118(10):3478-3490. 2542885, 18802496.
20. Huijskens EG, Reimerink J, Mulder PG, van Beek J, Meijer A, de Bruin E, Friesema I, de Jong MD, Rimmelzwaan GF, Peeters MF, Rossen JW, Koopmans M. Profiling of humoral response to influenza A(H1N1)pdm09 infection and vaccination measured by a protein microarray in persons with and without history of seasonal vaccination. PLoS One 2013, 8(1):e54890. 10.1371/journal.pone.0054890, 3554683, 23365683.
21. Bodewes R, Fraaij PL, Kreijtz JH, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 2012, 30(51):7407-7410. 10.1016/j.vaccine.2012.04.086, 22643217.
22. Choi YS, Baek YH, Kang W, Nam SJ, Lee J, You S, Chang DY, Youn JC, Choi YK, Shin EC. Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination. Clin Vaccine Immunol 2011, 18(9):1519-1523. 10.1128/CVI.05053-11, 3165229, 21813667.
23. Skowronski DM, de Serres G, Crowcroft NS, Janjua NZ, Boulianne N, Hottes TS, Rosella LC, Dickinson JA, Gilca R, Sethi P, Ouhoummane N, Willison DJ, Rouleau I, Petric M, Fonseca K, Drews SJ, Rebbapragada A, Charest H, Hamelin ME, Boivin G, Gardy JL, Li Y, Kwindt TL, Patrick DM, Brunham RC. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med 2010, 7(4):e1000258. 10.1371/journal.pmed.1000258, 2850386, 20386731.
24. Poland GA. The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine 2010, 28(Suppl 4):D3-D13.
25. Velan B, Kaplan G, Ziv A, Boyko V, Lerner-Geva L. Major motives in non-acceptance of A/H1N1 flu vaccination: the weight of rational assessment. Vaccine 2011, 29(6):1173-1179. 10.1016/j.vaccine.2010.12.006, 21167862.
26. Janjua NZ, Skowronski DM, Hottes TS, Osei W, Adams E, Petric M, Sabaiduc S, Chan T, Mak A, Lem M, Tang P, Patrick DM, De Serres G, Bowering D. Seasonal influenza vaccine and increased risk of pandemic A/H1N1-related illness: first detection of the association in British Columbia, Canada. Clin Infect Dis 2010, 51(9):1017-1027. 10.1086/656586, 20887210.
27. Casalegno JS, Ottmann M, Duchamp MB, Escuret V, Billaud G, Frobert E, Morfin F, Lina B. Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France. Clin Microbiol Infect 2010, 16(4):326-329. 10.1111/j.1469-0691.2010.03167.x, 20121829.
28. Lee VJ, Tan CH, Yap J, Cook AR, Ting PJ, Loh JP, Gao Q, Chen MI, Kang WL, Tan BH, Tambyah PA. Effectiveness of pandemic H1N1-2009 vaccination in reducing laboratory confirmed influenza infections among military recruits in tropical Singapore. PLoS One 2011, 6(10):e26572. 10.1371/journal.pone.0026572, 3203898, 22053196.
29. The Influenza A(H1N1)2009 Pandemic in Sweden, 2009-2010. [http://www.who.int/wer/2009/wer8409.pdf].
30. Berthoud TK, Hamill M, Lillie PJ, Hwenda L, Collins KA, Ewer KJ, Milicic A, Poyntz HC, Lambe T, Fletcher HA, Hill AV, Gilbert SC. Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP + M1. Clin Infect Dis 2011, 52(1):1-7. 10.1093/cid/ciq015, 3060888, 21148512.